Skip to main content
FEBS Open Bio logoLink to FEBS Open Bio
. 2022 Nov 17;12(12):2236–2249. doi: 10.1002/2211-5463.13518

Characterization of the promoter region of the murine Catsper2 gene

Andrea del Pilar Contreras‐Marciales 1, Sergio Federico López‐Guzmán 1, María Luisa Benítez‐Hess 1, Norma Oviedo 2, Javier Hernández‐Sánchez 1,
PMCID: PMC9714369  PMID: 36345591

Abstract

CATSPER2 (Cation channel sperm‐associated protein 2) protein, which is part of the calcium CATSPER channel located in the membrane of the flagellar principal piece of the sperm cell, is only expressed in the testis during spermatogenesis. Deletions or mutations in the Catsper2 gene are associated with the deafness‐infertility syndrome (DIS) and non‐syndromic male infertility. However, the mechanisms by which Catsper2 is regulated are unknown. Here, we report the characterization of the promoter region of murine Catsper2 and the role of CTCF and CREMτ in its transcription. We report that the promoter region has transcriptional activity in both directions, as determined by observing luciferase activity in mouse Sertoli and GC‐1 spg transfected cells. WGBS data analysis indicated that a CpG island identified in silico is non‐methylated; Chromatin immunoprecipitation (ChIP)‐seq data analysis revealed that histone marks H3K4me3 and H3K36me3 are present in the promoter and body of the Catsper2 gene respectively, indicating that Catsper2 is subject to epigenetic regulation. In addition, the murine Catsper2 core promoter was delimited to a region between −54/+189 relative to the transcription start site (TSS), where three CTCF and one CRE binding site were predicted. The functionality of these sites was determined by mutation of the CTCF sites and deletion of the CRE site. Finally, ChIP assays confirmed that CREMτ and CTCF bind to the Catsper2 minimal promoter region. This study represents the first functional analysis of the murine Catsper2 promoter region and the mechanisms that regulate its expression.

Keywords: Catsper2, CREM, CTCF, spermatogenesis, transcriptional regulation


CATSPER2 is necessary for sperm hyperactivation and male fertility. Here, we report the characterization of Catsper2 promoter region and identify a CpG island in silico. ChIP‐seq data analysis revealed that histone marks H3K4me3 and H3K36me3 are present in the promoter and body of the Catsper2 gene. Finally, CTCF and CREMτ bind to the Catsper2 core promoter and regulate its expression.

graphic file with name FEB4-12-2236-g006.jpg


Abbreviations

CATSPER

cation channel of sperm

CATSPER2

cation channel sperm‐associated protein 2

CRE

cAMP response element

CREM

cAMP responsive element modulator

CREMτ

cAMP responsive element modulator isoform τ

CTCF

CCCTC‐binding factor

EPD

eukaryotic promoter database

WGBS

whole genome bisulfite sequencing

CATSPER2 (Cation channel sperm‐associated protein 2), which has a sperm‐specific expression, is a mouse (Mus musculus) 588 a.a. protein that shares 67% identity with human CATSPER2. Along with other three trans‐membrane subunits (CATSPER1,3 and 4), five auxiliary subunits (CATSPER β, γ, δ, ε, ζ) and an EF‐hand calcium‐binding domain‐containing protein 9 (EFCAB9) compose the calcium channel located in the membrane of the flagellar principal piece of spermatozoid. Disruption of any CATSPER subunit produces male infertility by disturbing calcium concentration and preventing sperm hyperactivation [1, 2, 3, 4, 5, 6, 7]. Catsper gene expression varies through spermatogenesis; while Catsper1,3 and 4 are expressed in spermatids at late stages, Catsper2 is found in primary spermatocytes at earlier stages, suggesting an essential role for Catsper2 in the regulation of the other Catsper members [1, 2, 4, 5, 6, 8, 9, 10]. Interestingly, deletions or mutations in Catsper2 gene have been associated with patients with the deafness‐infertility syndrome (DIS) or non‐syndromic male infertility, highlighting the importance of Catsper2 gene in human male fertility. [11, 12, 13, 14, 15]. Even though the relevance of Catsper2 in male fertility is well established, the mechanism by which this gene is transcriptionally regulated is unknown. We previously reported that the cAMP Responsive Element Modulator τ isoform (CREMτ) regulates the CATSPER1 promoter activity in vitro [16]. CREMτ is a testis‐specific isoform of the Crem gene that contains a basic region and leucine zipper domains for CRE site recognition and DNA binding, in addition to 3 activation domains (Q1, Q2 and KID) for transcriptional activation [17, 18, 19]. Cremτ knockout mice exhibit male infertility due to post‐meiotic cell arrest and increased apoptotic germ cells [20]. Also, up to 101 genes involved in spermatogenesis were downregulated in Cremτ knockout mice [21]. On the other hand, CCCTC‐Binding Factor (CTCF) is a ubiquitous transcription factor relevant to male fertility that comprises 11 Zinc fingers for DNA‐binding [22]. Ctcf conditional knockout male mice are unable to procreate offspring, have smaller testes than wild‐type mice, and lots of genes, including Catsper2 were downregulated in these mice as shown by microarray assay [23]. Altogether, these data suggest that CREMτ and CTCF play a significant role in the transcriptional regulation of Catsper2. In this study, we report the functional analysis of the murine Catsper2 promoter region. The results indicate that CREMτ and CTCF transcription factors transactivate Catsper2 promoter through the binding to specific sites of the core promoter. Regulation of Catsper2 promoter by these factors may be crucial in mediating its specific expression in male germ cells.

Materials and methods

Animals

All the animals used in this work were bred according to the animal protocol 0113‐14 approved by the Internal Committee for the Care and Use of Laboratory Animals (CICUAL). CD1 mice were kept in polysulfonate cages with male mice, maintained in a 12 h light/dark cycle and provided with food and water ad libitum. CD1 mice were provided by the Unit for Experimentation and Production of Laboratory Animals (UPEAL) of the Center for Research and Advanced Studies (CINVESTAV), Mexico City, Mexico. Surgery was performed in accordance with the Ethical Guidelines and Procedures from the CICUAL. First, mice were euthanized by cervical dislocation, lower abdomen was then opened with surgical scissors and testes were exposed by pulling the epididymal fat. Later, testes were extracted, and tunica albuginea was removed with bistoury and finally washed with cold 1× PBS.

RNA extraction and reverse transcription polymerase chain reaction (RT‐PCR)

For cloning CREMτ transcription factor, RT‐PCR was performed from mouse testis; total RNA was extracted using the TRIzol® reagent (Invitrogen, Waltham, MA, USA), according to the manufacturer's instructions. The cDNA was prepared from total RNA using a High‐Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Waltham, MA, USA). PCR reactions were conducted with 1 U Phusion DNA Polymerase (New England Biolabs, Ipswich, MA, USA), 1× buffer HF, 200 mm dNTPs, 0.2 μm primers (Table 1), and 1 μL cDNA. The 1134 bp fragment of the CREMτ open reading frame (ORF) was cloned into pjet 2.1 blunt vector and then subcloned into pcDNA3 expression vector (pcDNA3‐CREMτ).

Table 1.

Primers used in this work.

Reaction Name Sequence (5′–3′) Product length (bp) Templates
Transcription Factor cloning CREMτ Fwd ggatccaataatgagcaaatgtggcagg 1134 Testis total RNA
CREMτ Rev ctcgaggcaactgtacatgctgtaatcag
Promoter cloning Cats2F/−1309 tgaagcttgtttgaattaagggtcattgtg 1598 Genomic DNA
Cats2R/+289 tgaagcttctgacatttggaaaacgtgtc
Cats2F/−509 tgaagcttggcctgctagatagtggag 798, 698
Cats2F/−215 tgctcgaggagaaatgagatgggagag 504
Cats2F/−54 tgctcgagaacagctggtaactgcc 343, 243
Cats2F/+3 tgctcgaggcgaacgcccg 287
Cats2R/+189 tgaagctttcgcgggcctcacttcc
Sequencing constructions RVPrimer3 ctagcaaaataggctgtccccag
Luc2Rev gtcccgtcttcgagtgggtag
CMV Fwd cgcaaatgggcggtaggcgtgt
BGH Rev cctcgactgtgccttcta
Mutagenesis mCTCF1 Fwd gcggaacagctggtattcttattgtggcgggcgcgcggg pCat2‐243 plasmid
mCTCF1 Rev cccgcgcgcccgccacaataagaataccagctgttccgc
mCTCF2 Fwd gggcgcgcggggcgattcttattgttcgcttaggcgaacgc
mCTCF2 Rev gcgttcgcctaagcgaacaataagaatcgccccgcgcgccc
mCTCF3 Fwd agccggagcggcccttattcttgcccgctggggaggag
mCTCF3 Rev ctcctccccagcgggcaagaataagggccgctccggct
ΔCREMτ Fwd gccggcgcggaaggcggaggtgagtgggcggaagtgaggc 229
ΔCREMτ Rev gcctcacttccgcccactcacctccgccttccgcgccggc

Molecular cloning and sequence analysis

The Eukaryotic Promoter Database (EPD, https://epd.epfl.ch//index.php) was used to predict the putative promoter region of the murine Catsper2 gene. The gene‐specific primers (Cats2F/−1309 and Cats2R/+289, Table 1) were designed to amplify a putative 1598‐bp promoter region of the murine Catsper2 gene (NCBI accession NC_000068.8 from 121245582 to 121243985) including the transcriptional start site (+1). PCR amplification was performed using genomic DNA from CD1 mouse testis as a template and Phusion DNA Polymerase (New England Biolabs, Ipswich, MA, USA). The 1598‐bp fragment of the putative Catsper2 promoter was cloned into pjet 1.2 blunt vector. This region was used as a template for amplifying a 798‐bp fragment containing a shorter promoter region (primers Cats2F/−509 and Cats2R/+289, Table 1) which was also cloned into pjet 1.2 blunt vector. Both fragments (1598‐ and 798‐bp) were subcloned in sense (pCat2‐1598 and pCat2‐798) and antisense (pCat2‐1598AS and pCat2‐798AS) directions using two flanking HindIII sites into the Photinus luciferase reporter vector pGL4.10. The potential TF‐binding sites were identified using promo (http://alggen.lsi.upc.es/cgi‐bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3) and tf‐bind (https://tfbind.hgc.jp) and CpG islands were predicted with methprimer (http://www.urogene.org/methprimer/). Sequence alignment was performed using clustalx v2.1 (http://www.clustal.org/clustal2/).

ChIP‐seq data analysis

ChIP‐seq data collected from the NCBI GEO and the sequence read archive (SRA) databases (Table 2) were analyzed as previously described [24] with minor modifications. Short read sequences were extracted in fastq format from the downloaded data in SRA format using sratoolkit (version 2.10.8). The extracted sequences were mapped to the mouse reference genome (mm10) with bowtie2 (version 2.3.5.1) [25]. The alignment parameter was set to default. ChIP‐seq peaks were identified using macs2 [26] with – nomodel parameter. Then, the ChIP‐seq enrichment calculations were performed with bamCompare from the deeptools suite (version 3.3.2) [27]; the normalization method was Bins Per Million mapped reads (BPM) with a bin size of 20 (‐‐extendReads 150). The resulting comparison values for Catsper2 gene and promoter region were plotted. Only the run with a higher number of spots for the samples with duplicate experiments was analyzed.

Table 2.

ChIP‐seq data.

Histone mark Cells/tissue Access number Database Ref.
H3K4me3 Spermatocyte pachytene

SRX336649 (A)

SRX336651 (I)

SRA [28]
Round spermatids

SRX336652 (A)

SRX336654 (I)

SRA [28]
Testis 8 weeks

GSM1000079 (SRR566800) (A)

GSM1000203 (SRR566962) (I)

GEO [29]
Liver 8 weeks

GSM769014 (SRR317233) (A)

GSM769034 (SRR317274) (I)

GEO [29]
H3K36me3 Testis 8 weeks

GSM1000067 (SRR566775) (A)

GSM1000203 (SRR566962) (I)

GEO [29]
Liver 8 weeks

GSM1000151 (SRR566943) (A)

GSM769034 (SRR317274) (I)

(A), Antibody sample; (I), Input sample.

Whole genome bisulfite sequencing data analysis

To analyze and compare the methylation status of the CpG island found in silico, whole‐genome bisulfite sequencing (WGBS) data were collected from ENCODE project in BigWig format [30, 31]. The methylation status for Catsper2 promoter region in spermatogenic cells and control tissues were plotted.

Construction of Catsper2 promoter deletions

Deletions of the 5′ and 3′ ends of the mouse Catsper2 promoter were constructed using primers: Cats2F/−509_Cats2R/+189, Cats2F/−215_Cats2/+289, Cats2F/−54_Cats2R/+289, Cats2 P4/Cats2 P‐Rev2 (−54/+189) and Cats2 P5/Cats2 P‐Rev (+3/+289). PCR fragments were generated using pCat2‐798 as a template, cloned into pjet 1.2 blunt vector, and subcloned in sense containing XhoI and HindIII sites into pGL4.10 vector. These plasmids were named pCat2‐698, pCat2‐504, pCat2‐343, pCat2‐243 and pCat2–287, respectively. The integrity and orientation of all constructions were confirmed by automatic DNA sequencing with RVPrimer3 and Luc2Rev primers (Table 1).

Site‐directed mutagenesis

Predicted CREMτ and CTCF binding sites from the pCat2‐243 construct were mutated using the Quick‐Change Site‐Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) with the appropriate primers (Table 1). PCR was performed under the following conditions: 94 °C for 5 min; 40 cycles of 94 °C for 30 s, 68 °C for 6 min; and finally, 68 °C for 10 min. The reaction product was treated with DpnI and transformed into Escherichia coli DH5α competent cells and analyzed by sequencing.

Cell culture and transfection

Type B spermatogonia GC‐1 spg and mouse Sertoli MSC‐1 cell lines were cultured in DMEM (Sigma, St. Louis, MO, USA) supplemented with FBS 10%, Penicillin (5 U·mL−1) and Streptomycin (5 mg·mL−1; 1%) and incubated at 37 °C in a humidified atmosphere with 5% CO2. Cells grown to 80% confluency were seeded in 24 well plate (1 × 105 cells per well) 24 h before transfection. Cell transfections were performed with the K2® Transfection System (Biontex, München, Germany) according to the manufacturer's protocol with 500 ng of Catsper2 reporter plasmids. Co‐transfections were made using 250 ng of Catsper2 promoter plasmids and 250 ng of CREMτ‐expressing (pcDNA3‐CREMτ) or CTCF‐expressing vector (pcMV6, OriGene, Rockville, MD, USA) and 0.4 ng of pRL‐CMV normalization vector. The pGL4.10‐CMV and empty pGL4.10 vectors were used as positive and negative controls, respectively.

Luciferase assay

Two days (48 h) after transfections, cells were washed with sterile 1× PBS and lysed, and the transcriptional activity was quantified using the Dual‐GLO Luciferase Assay System (PROMEGA, Madison, WI, USA) as described in the manufacturer's protocol. The relative luciferase activities were measured with a Fluoroskan Ascent reader (Thermo Fisher Scientific, Waltham, MA, USA). Luciferase activity was normalized to pRL–CMV activity and expressed as fold change relative to the activity of empty vector pGL4.10 (defined as 1). Data are presented as mean ± SEM of three independent experiments in triplicate.

Immunodetection of CREMτ and CTCF

Total protein was extracted from GC‐1 spg cells 48 h after transfection with RIPA buffer containing 1 mm PMSF and Complete 1× (Roche, Basel, Switzerland), and protein concentration were determined by Bradford method (BioRad, Hercules, CA, USA). Protein samples were separated by 10% SDS/PAGE and subsequently transferred to a Polyvinylidene difluoride membrane (PVDF; BioRad). Membranes were blocked with 5% ProPure milk (Amresco, Solon, OH, USA) in TBS‐T buffer (Tris‐buffered saline, 0.1% Tween 20) 1 h and then incubated overnight with antibody diluted in blocking buffer including Santa Cruz (Dallas, TX, USA) antibodies anti‐CTCF (sc‐271474) anti‐CREM (sc‐39426), anti‐MYC (sc‐40), 1 : 500 dilution and anti‐GAPDH (sc‐365062), 1 : 1000 dilution. Finally, for CREMτ assay, membranes were incubated with a rabbit Anti‐Mouse IgG Polyclonal Antibody, Horseradish Peroxidase (HRP) conjugated (Cat. No. 61‐6520; Invitrogen, Waltham, MA, USA) 1 : 3000 dilution in blocking buffer for 1 h. The peroxidase was developed using Immbilon Forte Western HRP substrate (WBLUF0100; MilliporeSigma, St, Louis, MO, USA). For CTCF assay, membranes were incubated with AP‐Goat anti‐Mouse IgG (H + L; Cat. No. 62‐6522; Invitrogen) 1 : 1000 dilution in blocking buffer for 1 h and the bands were developed with BCIP®/NBT Liquid Substrate System (Cat. No. B1911; Sigma).

Chromatin immunoprecipitation (ChIP) assay

Protein‐DNA complexes were prepared from the testis or liver of adult mice (n = 3). The ChIP assay was performed according to the X‐ChIP protocol from the Abcam protocols book (https://docs.abcam.com/pdf/misc/abcam‐protocols‐book.pdf) with minor modifications. Briefly, the complexes were preserved by fixing the cells in 1% formaldehyde for 30 min at room temperature and neutralization with glycine. The cells were then washed, lysed, and sonicated to shear DNA into fragments of 200–1000 bp; 10% was saved as input. DNA‐protein complexes were immunoprecipitated with 2 μg CTCF (sc‐271514X; Santa Cruz, Dallas, TX, USA), CREM (sc‐39426; Santa Cruz), or irrelevant IgG MHC Class II (14‐5321‐81; eBioscience, Waltham, MA, USA) antibody overnight at 4 °C. The immune complexes were isolated with protein G agarose beads (sc‐2002; Santa Cruz), eluted with salts, and finally, the crosslinking was reversed and digested with proteinase K. The DNA was then purified with the phenol‐chloroform method. The binding of transcription factors to the Catsper2 promoter was assessed by standard PCR using the primers listed in Table 1. The IgG sample and liver tissue were used as negative controls. Densitometric analysis of CTCF and CREM ChIP–PCR signals was performed using imagej software (https://imagej.nih.gov/ij/index.html), quantified as electronic density (pixels) and plotted as IgG relative expression. Data are presented as mean ± SEM of three independent experiments.

Statistical analysis

Statistical analysis was performed using graphpad prism 6 (GraphPad, San Diego, CA, USA). One‐way ANOVA and paired Student's t‐test were used to determine significant differences. Data show mean ± SEM (n = 9) from three independent experiments performed in triplicate; P < 0.05 was considered statistically significant.

Results

Identification of the murine Catsper2 promoter and its regulatory elements

The potential Catsper2 promoter region was analyzed using The Eukaryotic Promoter Database. Two putative promoters of 601 and 784 bp were found, between −1289 to −689 and −500 to +284 relative to +1 transcription start site, respectively. The putative Catsper2 promoter sequence containing the 1598 bp region (−1309 and +289) was obtained from the National Center for Biotechnology Information (NCBI) and further analyzed to search for regulatory elements. The promoter region near Catsper2 contained neither a TATA consensus box nor a CCAAT consensus box near the TSS. In addition, a CpG island from −536 to +189 was detected with the methprimer software (Fig. 1A). Several transcription factor binding sites were predicted using promo and tf‐bind, including SOX, CTCF and CRE sites; only CRE and CTCF binding sites were found in the 784 bp promoter around the TSS (Fig. 1A).

Fig. 1.

Fig. 1

Regulatory elements of the mouse Catsper2 promoter. (A) Red arrow marks the transcription start site designated as +1. Putative promoters predicted with eukaryotic promoter database are enclosed with blue dashed lines and primer alignment sequences for plasmid constructs are highlighted in gray. A predicted CpG island is underlined in black, the putative transcription factor sites are boxed, and their corresponding names are shown above. (B) Methylation status of the CpG island found at the mouse Catsper2 promoter based of WGBS data analysis. The WGBS data for spermatogonias, spermatocytes, spermatids, liver, and spleen were obtained from ENCODE and plotted in the promoter region of murine Catsper2 gen; scale denotes unmethylated CpG sites as 0 and fully methylated sites as 1, represented in gray color. (C) Histone H3K4 trimethylation pattern at the mouse Catsper2 locus based on ChIP‐seq analysis. The ChIP‐seq data for H3K4me3 in spermatocytes (pachytene), round spermatids (Roundsp), testis and liver were analyzed as described in materials and methods, the H3K4me3 signal is represented in green color. The light gray lines and rectangles represent the structure of the murine Catsper2 gene, and the first exon and part of the first intron of the divergent Pdia3 gene. Red arrow marks the transcription start site.

CpG islands are regions of DNA with a high‐GC content and high frequency of CpG dinucleotides that have been strongly correlated to promoter regions and transcription initiation [32, 33]. The methylation status of the CpG island in the Catsper2 promoter in testis and other tissues was evaluated through WGBS data analysis; as shown in Fig. 1B, the DNA of the region containing the murine Catsper2 promoter is found non‐methylated in both spermatogenesis cells and liver and spleen tissues, which agrees with previous reports indicating that CpG islands associated with promoter regions do not usually show a tissue‐specific methylation pattern [34].

The histone mark H3K4me3 has been associated with a signature of a transcriptionally active promoter region [35, 36, 37]. To clarify whether the predicted Catsper2 promoter region was functional in vivo, we performed H3K4me3 ChIP‐seq data analysis in mouse germ cells at different stages of spermatogenesis and whole testis and liver as controls (see Table 2 and Fig. 1C). As expected, we found the H3K4me3 modification enriched near the TSS of germ cells and whole testis, suggesting that the predicted promoter region has transcriptional activity. Nonetheless, we also observed the presence of this histone modification in liver tissue where Catsper2 is not expressed. This fact can be attributed to the proximity of the Pdia3 transcription start site, which is a ubiquitous gene [38, 39]. Thereby, the Catsper2 promoter region lying from −1309 to +289 was selected for further transcriptional analysis.

Transcriptional activity of the putative murine Catsper2 promoter regions

The fragments containing the putative promoters, the 1598 bp (from −1309 to +289) and 798 bp (−509 to +289) regions were cloned upstream of the luciferase reporter gene in pGL4.10 vector (pCat2‐1598 and pCat2‐798, respectively, Fig. 2A) to analyze the transcriptional activity of the Catsper2 promoter. Both constructs were transiently transfected into GC‐1 spg and MSC‐1 cells and luciferase activities were then measured. Luciferase assays showed a 6.1‐ and 83.9‐fold increase in the promoter activity for pCat‐1598 compared to the promoterless vector pGL4.10 in GC‐1spg and MSC‐1, respectively. Meanwhile, the 800 bp 5′ deletion (pCat2‐798) revealed a transcriptional activity of 11.7‐ and 100.2‐fold increase in GC‐1spg and MSC‐1, respectively (Fig. 2B). These results indicate that the −509 to +289 region of Catsper2 (pCat2‐798) contains a functional promoter. In addition, pCat2‐1598AS and pCat2‐798AS constructs containing putative Catsper2 promoters in antisense also exhibited a transcriptional activity. The first construct showed an increase of 6.9 and 71.0 in GC‐1 spg cells and MSC‐1, and the second 17.2 and 103, respectively, suggesting that the divergent Pdia3 gene promoter overlaps with Catsper2 promoter or alternatively, Catsper2 promoter may be bidirectional.

Fig. 2.

Fig. 2

Transcriptional activity of the mouse Catsper2 promoter. (A) a 1598 bp region containing the two predicted promoters and a 798 bp region containing only the putative promoter including the TSS (+1) were inserted upstream of the luciferase gene into vector pGL4.10[Luc2] (pCat2‐1598 and pCat2‐798, respectively). (B) both constructs were transiently transfected into the MSC‐1 and GC‐1 spg cell lines and the cells were harvested for luciferase assays after 48 h. these two regions were cloned in antisense (pCat2‐1598AS and pCat2‐798AS) and used as negative controls. Luciferase activities represent fold‐increments relative to the empty vector activity and are expressed in relative units, defined as the ratio of Photinus luciferase to Renilla luciferase activities. Data represent mean ± SEM (n = 9) of three independent experiments, each performed in triplicate. One‐way ANOVA was used to identify significant differences (*P < 0.05, **P < 0.01 and ***P < 0.001). (C) Histone H3K36 trimethylation patterns at the mouse Catsper2Pdia3 locus based on the ChIP‐seq analysis. The ChIP‐seq data for H3K36me3 in 8‐week‐old mouse testis and liver for the region comprising the Catsper2 and Pdia3 genes were plotted. The light gray lines and rectangles represent the structure of the murine Catsper2 and Pdia3 genes. The black dashed lines show a normalized 2‐fold change from the input samples of each tissue. Red arrows mark the transcription start sites.

The histone mark H3K36me3 has been widely studied and related to transcriptional elongation since this mark can be detected on the body of transcriptionally active genes [40]. In addition, H3K36me3 modification may be one of the ways transcription is regulated in differentially expressed bidirectional promoters [41]. To further investigate the possible bidirectionality of the Catsper2 promoter, previously reported ChIP‐seq data from testis and liver for the histone mark H3K36me3 were plotted (see Table 2 and Fig. 2C). Histone H3K36me3 mark was found throughout Catsper2 gene in testis, similar to Pdia3, while a stronger H3K36me3 signal is observed in Pdia3 gene in the liver.

Delimiting Catsper2 core promoter

Deletion fragments were generated by PCR from the pCat2‐798 construct and subcloned into promoterless pGL4.10 reporter vector to determine the Catsper2 basal promoter sequence with transcriptional activity. Deletion constructs were transfected into GC‐1 spg and MSC‐1 cells, and the transcriptional activity was measured by the luciferase activities of the reporter gene. The 100 bp deletion at the 3′ end (pCat2‐698) generated a 2.3‐fold increase in transcriptional activity in GC‐1 spg cells compared to the pCat2‐798 construct, and no change was observed in MSC‐1 cells (Fig. 3). In addition, a 5′ deletion of 294 bp (pCat2‐504) showed a 1.7‐ and 2.1‐fold increase in transcriptional activity both in GC‐1 spg and MSC‐1 cells, respectively, compared with pCat2‐798. Interestingly, as the 5′ end was further shortened to −54, the transcriptional activity for the pCat2‐343 construct decreased 1.1‐ and 2‐fold in GC‐1 spg and MSC‐1 cells, respectively. For the pCat2‐243 construct, a 3.3‐fold decrease was observed in GC‐1 spg cells compared with pCat2‐798. However, plasmid pCat2‐243 still showed statistically significant activity, a 3.5‐fold increase in GC‐1 spg cells compared with the empty vector, in contrast to the null transcriptional activity of the pCat2‐287 construct lacking TSS in GC‐1 spg cells. Deletion of TSS (pCat2‐287) did not abolish the transcriptional activity in MSC‐1 cells, which may be due to an alternative TSS. In addition, the difference in transcriptional activity of the Catsper2 promoter in MSC‐1 and GC‐1 spg lines should be the result of the relative levels of the repressing and activating factors of the CREM and CREB families expressed in these cell lines considering that both families of transcription factors bind to CRE sites with the same affinity [42, 43]. These results suggest that the minimal Catsper2 promoter sequence necessary for basal transcriptional activity both in GC‐1 spg and MSC‐1 cells lies between −54 and +189 relative to the TSS.

Fig. 3.

Fig. 3

Deletion analysis of mouse Catsper2 promoter. Plasmids with deletions at the 5′, 3′ or both ends of the Catsper2 promoter were co‐transfected into GC‐1 spg and MSC‐1 cells using pRL‐CMV vector as a control of transfection efficiency. The positions are numbered according to TSS (+1), potential CRE and CTCF sites are indicated by gray and white boxes, respectively. Luciferase activities were calculated as in Fig. 2. Data are presented as the mean ± SEM (n = 9) of three independent experiments, each performed in triplicate. *Significant differences compared to the activity of pGL4.10. #Significant differences compared to pCat2‐798. One‐way ANOVA was used to determine statistical differences (***P < 0.001).

CTCF and CREMτ enhance Catsper2 promoter transcriptional activity

The in silico analysis of the minimal Catsper2 promoter region (−54/+189) indicates the presence of three CTCF sites (CTCF1, CTCF2, and CTCF3) and one CRE binding site (Fig. 1A). Furthermore, CTCF and CRE sites are conserved in mouse, rat, and human species, as shown in the multiple sequence alignment of this region (Fig. 4A), suggesting these TFs regulate Catsper2 promoter. To ascertain the role of CTCF and the CREMτ in the transcriptional activity of Catsper2 promoter, three CTCF sites were mutated (CTCF1‐3), and a CRE site (ΔCRE) was deleted in the core promoter of Catsper2 (pCat2‐243) by site‐directed mutagenesis (Fig. 4B,C), and the promoter activity was evaluated in GC‐1 spg cells. To further assess the relevance of CTCF and CREMτ in Catsper2 regulation, plasmids containing Ctcf or Cremτ ORFs were co‐transfected with the wild‐type or mutant promoter constructs. Overexpression of recombinant proteins in GC‐1 spg cells was verified by western blot with specific antibodies (Fig. 4D).

Fig. 4.

Fig. 4

CRE and CTCF sites are conserved in mouse, rat, and human; these factors regulate Catsper2 promoter activity in GC‐1 spg. (A) the sequences of the promoter regions of the mouse, rat and human Catsper2 gene were aligned by ClustalX; putative CTCF and CRE binding sites are labeled and the NCBI‐predicted TSS of human (+), mouse (*) and rat (^) Catsper2 genes and the coordinates of the murine minimal promoter are indicated. (B) Plasmids pCat2‐243 and derived mutants ΔCRE or (C) CTCF (1), CTCF (2), CTCF (3) were transiently co‐transfected with pCREMτ (pcDNA3‐Cremτ) or pCTCF (pCMV6‐CTCF), respectively, into GC‐1 spg cells and the cells were harvested for luciferase assays after 48 h. the luciferase activities represent the fold change over pCat2‐243 construct. Data indicate mean ± SEM (n = 9) of three independent experiments, each performed in triplicate. Paired student t‐test was used to detect significant differences (*P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001). #Significant differences compared to pCat2‐243 basal activity. (D) Total protein from GC‐1 spg cells transfected with the constructs containing the Ctcf and Cremt genes (overexpression) and non‐transfected (control) was analyzed by western blot. Upper panels, endogenous and recombinant proteins were detected with specific antibodies (anti‐CREM and anti‐CTCF); lower panels, GAPDH and c‐MYC proteins were detected as loading control. Experiments of transfection were performed by triplicate.

Overexpression of CREMτ or CTCF in GC‐1 spg cells provoked a 1.93‐ and 1.74‐ fold increase in the core promoter (pCat2‐243) transcriptional activity, respectively (Fig. 4B,C), suggesting that these transcription factors regulate murine Catsper2 promoter. Likewise, deletion of the CRE site caused a 2.41‐fold increase over pCat2‐243 promoter activity, suggesting a repressive role for this site in GC‐1spg cells. The enhanced activity of the ΔCRE mutant was not changed by overexpression of CREMτ, which may be due to the deletion of the unique CRE target site (Fig. 4B). Regarding the CTCF binding sites, mutation of CTCF1 and CTCF2 reduced pCat2‐243 transcriptional activity (1.92‐ and 4.35‐fold, respectively), and no change was observed with CTCF3 mutant. CTCF overexpression increased the transcriptional activity of all three mutants and the CTCF3 mutant site showed the greatest activity (2.95‐fold change) relative to the wild‐type promoter construction (Fig. 4C). These results suggest that CTCF1, CTCF2, and CRE sites participate in the transcriptional regulation of Catsper2 core promoter.

CTCF and CREMτ bind to Catsper2 core promoter in vivo

The aforementioned results suggest that CTCF and CREMτ regulate Catsper2 promoter activity, possibly by binding to their specific sites in the core promoter. Therefore, ChIP assays were performed to assess the interaction of CTCF and CREMτ with Catsper2 core promoter in vivo. Fragmented DNA from testes or liver chromatin was precipitated with anti‐CTCF, anti‐CREM or irrelevant anti‐MHC Class II (IgG) and then subjected to PCR.

ChIP results revealed the amplification of a specific region from Catsper2 core promoter for both transcription factors in the testis samples. No signal was detected with the control MHC Class II antibody (Fig. 5). These results demonstrate that CTCF and CREMτ bind in a tissue‐specific manner to the murine Catsper2 core promoter in vivo, corroborating their participation in Catsper2 promoter regulation.

Fig. 5.

Fig. 5

CREMτ and CTFC bind to murine Catsper2 promoter in vivo. (A) ChIP‐PCR products were amplified with Cats2F/−54 and Cats2R/+189 primers for CREMτ and CTCF. Fragmented testicular chromatin was immunoprecipitated with anti‐CREM or anti‐CTCF antibody. MHC‐II antibody was used as a negative isotype specific (IgG) control, while liver chromatin as a non‐specific target binding control. Input DNA samples represent total chromatin. PCR products were separated in agarose gel (n = 3). (B) Densitometric analysis of CTCF and CREM ChIP‐PCR signals using imagej. Paired student t‐test was used to detect significant differences (*P < 0.05 and **P < 0.01).

Discussion

Catsper2 gene, which codes for one of the main subunits of the CATSPER channel, is specific for spermatogenesis and essential for sperm hyperactivation and male fertility in both mice and humans [1, 11, 12, 13, 14, 15, 44]; The relevance of Catsper2 gene in human male fertility has been evidenced by deletions or mutations in Catsper2 gene associated with patients with deafness‐infertility syndrome (DIS) or non‐syndromic male infertility [11, 12, 13, 14, 15]; therefore, it is important to elucidate its transcriptional regulation mechanisms to explore whether there is a relationship with some cases of male infertility and to have a possible target in the development of male contraceptives. Here, we describe for the first time the murine Catsper2 promoter region and some of the mechanisms that may be involved in its tissue‐specific expression. We found in silico the putative promoter in a region of approximately 1600 bp that includes the transcriptional start site (TSS +1); although, the transcriptional functional proximal promoter was delimited to a region of about 800 bp. An interesting finding was the transcriptional activity of the promoter region of Catsper2 in antisense consistent with the head‐to‐head gene display of Pdia3 in the mouse genome assembly GRCm39, which unlike Catsper2 is a ubiquitous gene [38, 39]. Therefore, these results suggest that the promoter of the divergent Pdia3 gene is found in the same region. Alternatively, Catsper2 promoter may behave as a bidirectional promoter, as reported for some promoters whose genes are expressed in spermatogenesis [24, 45, 46].

H3K4me3 mark has been widely related to active promoter regions [35, 36, 37]. In this regard, a clear signal of the H3K4me3 mark over the predicted Catsper2 promoter region in testis, late‐spermatocytes, and early spermatids was observed by ChIP‐seq data analysis. This evidence agrees with the reported Catsper2 expression pattern in these cells [1, 44]; however, we also found the H3K4me3 signature in the liver. Therefore, the H3K4me3 mark keeps this chromatin region open so that transcription initiation occurs in the antisense direction for the ubiquitous Pdia3 gene. In contrast, Catsper2 transcription may be regulated by other epigenetic mechanisms as well as by specific transcription factors during spermatogenesis.

H3K36me3 is a histone mark, that has been related to transcription elongation and bidirectional promoters [40, 41]. Bidirectionality is consistent with the different expression patterns of Catsper2Pdia3, which appear to be regulated by the same promoter region since our luciferase assays showed that this region has transcriptional activity in both directions. According to ChIP‐seq data analysis, the presence of H3K36me3 on Catsper2, in contrast to Pdia3, is only found in testis, suggesting that H3K36me3 mark may be one of the factors contributing to the tissue‐specific expression of the Catsper2 gene.

Unlike Catsper1, a CpG island was predicted by bioinformatic analysis in Catsper2 promoter [47]. Most of the promoters contain CpG islands [48] and have been linked to TATA‐less promoters as is the case of the Catsper2 promoter. Additionally, the histone methylation marks in Catsper2 promoter region derived from ChIP‐seq data analysis are consistent with the genome‐wide studies that have associated promoter regions containing high CpG dinucleotide frequency with the H3K4me3 modification [33]. The same mark that has been proposed as one of the ways to prevent DNA methylation in these regions; this agrees with WGBS data analysis of the Catsper2 promoter region.

Transcription factors also play a fundamental role in the regulation of gene expression [49]; and the predicted transcription factor binding sites of interest are concentrated in a region close to the TSS, which is related to the definition of a proximal promoter [50, 51]. We found that the minimal promoter of Catsper2 comprises a 243 bp region (−54 to +189), including part of exon 1. Previously, the minimal promoter of murine Catsper1 was found in a 394 bp region (−287 to +107), which also includes more than 100 bp of the first exon [47], suggesting that the 3′ region plays a relevant role in the regulation of Catsper1‐4 gene promoters. Transcription factors regulating a promoter are usually conserved in different species [52]. Indeed, sequence alignment of the Catsper2 minimal promoter region reveals that all four predicted TFs binding sites (one CRE and three CTCF) are conserved among mouse, rat and human species.

CRE sites are approximately 150 bp near the TSS in haploid germ cells, and 40% of these sites are known as half‐CRE since only half of the bases of the CRE consensus sites are found [43]; this is consistent with a half‐CRE site predicted in the Catsper2 promoter (+152).

CREMτ activates various genes during spermatogenesis, including Catsper1; however, most are expressed in post‐meiotic stages [16, 53, 54, 55, 56, 57, 58, 59]. Repressor isoforms of the CREM protein (CREMα, CREMβ and CREMγ) are expressed in spermatogonia (GC‐1 spg) cells [42]; so, deletion of the only CRE site of the minimal promoter results in an increased transcriptional activity. On the other hand, overexpressing the activator isoform CREMτ does not further increase the minimal promoter's transcriptional activity, lacking the only target CRE site (ΔCRE). This agrees with the enhanced transcriptional activity of the wild‐type Catsper2 minimal promoter under CREMτ overexpression, where CREMτ surpasses the endogenous repressor isoforms to bind CRE site. As spermatogenesis progresses and the levels of CREM repressor isoforms decrease, Catsper2 transcription starts, and later, in the post‐meiosis stage, CREMτ can use the CRE site of the Catsper2 promoter to increase its expression levels; however, further investigation needs to be done to confirm this hypothesis.

On the contrary, of all the CTCF sites in the genome, only 6% contain all four modules, 38% the core motif plus another module, and the rest only the core motif [60]. Mutation of CTCF1‐2 sites reduces Catsper2 promoter activity, indicating that these sites are essential in regulating this promoter. According to the results of the mutant CTCF binding sites, CTCF2 is the most relevant site for Catsper2 minimal promoter since its mutation dramatically reduces the transcription and the specific factor fails to increase the activity to the levels of the wild‐type promoter sequence or mutant CTCF1 construct. Another interesting result to highlight is that CTCF3 site does not influence the basal activity of Catsper2 minimal promoter, but for an unknown reason it prevents a greater transcriptional activation by CTCF protein through the CTCF1‐2 sites, leading to an enhanced activity of Catsper2 promoter containing the mutant CTCF3.

In addition, the presence of CTCF‐binding sites has also been associated with promoters containing the H3K4me3 mark [61], demonstrating that these mechanisms are involved in the regulation of the Catsper2 expression.

Finally, the regulatory mechanisms described here may be part of tissue‐specific regulation of Catsper2 since the binding of both transcription factors to the basal Catsper2 promoter only takes place in the testis according to the ChIP assay.

Conclusions

Here, we show the first evidence for transcriptional regulation of Catsper2 gene in the mouse model and spermatogonia cells. Our analysis suggests that the Catsper2 promoter is under epigenetic regulation through H3K4me3 and H3K36me3 histone marks and a CpG island. Finally, our results show that this promoter region is regulated by the transcription factors CTCF and CREMτ; however, the exact molecular pathway and cellular stages have yet to be elucidated.

Conflict of interest

The authors declare no conflict of interest.

Author contributions

All the authors were involved in the overall study design. JH‐S, NO, MLB‐H, APC‐M, and SFL‐G conceived the experiments; APC‐M and SFL‐G conducted the experiments, analyzed the results, and drafted the manuscript; JH‐S, NO, APC‐M and SFL‐G reviewed the manuscript. All the authors have read and agreed to the published version of the manuscript.

Acknowledgements

We are indebted to Dr Patricia Talamás Rohana from the Department of Infectomics and Molecular Pathogenesis, CINVESTAV, México for the luminometer reading support. Graphical abstract created with BioRender.com. We thank CONACyT Fellowships for APC‐M (773382) and SFL‐G (777856).

Andrea del Pilar Contreras‐Marciales and Sergio Federico López‐Guzmán contributed equally to this work.

Edited by Beáta Vértessy

Data accessibility

The data supporting this study's findings are available from the corresponding author (javierh@cinvestav.mx) upon reasonable request.

References

  • 1. Quill TA, Ren D, Clapham DE, Garbers DL. A voltage‐gated ion channel expressed specifically in spermatozoa. Proc Natl Acad Sci USA. 2001;98:12527–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ren D, Navarro B, Perez G, Jackson AC, Hsu S, Shi Q, et al. A sperm ion channel required for sperm motility and male fertility. Nature. 2001;413:603–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Lobley A, Pierron V, Reynolds L, Allen L, Michalovich D. Identification of human and mouse CatSper3 and CatSper4 genes: characterisation of a common interaction domain and evidence for expression in testis. Reprod Biol Endocrinol. 2003;1:53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Liu J, Xia J, Cho K‐H, Clapham DE, Ren D. CatSperbeta, a novel transmembrane protein in the CatSper channel complex. J Biol Chem. 2007;282:18945–52. [DOI] [PubMed] [Google Scholar]
  • 5. Wang H, Liu J, Cho K‐H, Ren D. A novel, single, transmembrane protein CATSPERG is associated with CATSPER1 channel protein. Biol Reprod. 2009;81:539–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Chung J‐J, Navarro B, Krapivinsky G, Krapivinsky L, Clapham DE. A novel gene required for male fertility and functional CATSPER channel formation in spermatozoa. Nat Commun. 2011;2:153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Chung J‐J, Miki K, Kim D, Shim S‐H, Shi HF, Hwang JY, et al. CatSperζ regulates the structural continuity of sperm Ca(2+) signaling domains and is required for normal fertility. eLife. 2017;6:e23082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Schultz N, Hamra FK, Garbers DL. A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci USA. 2003;100:12201–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Jin J‐L, O'Doherty AM, Wang S, Zheng H, Sanders KM, Yan W. Catsper3 and catsper4 encode two cation channel‐like proteins exclusively expressed in the testis. Biol Reprod. 2005;73:1235–42. [DOI] [PubMed] [Google Scholar]
  • 10. Qi H, Moran MM, Navarro B, Chong JA, Krapivinsky G, Krapivinsky L, et al. All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility. Proc Natl Acad Sci USA. 2007;104:1219–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Avidan N, Tamary H, Dgany O, Cattan D, Pariente A, Thulliez M, et al. CATSPER2, a human autosomal nonsyndromic male infertility gene. Eur J Hum Genet. 2003;11:497–502. [DOI] [PubMed] [Google Scholar]
  • 12. Zhang Y, Malekpour M, Al‐Madani N, Kahrizi K, Zanganeh M, Lohr NJ, et al. Sensorineural deafness and male infertility: a contiguous gene deletion syndrome. J Med Genet. 2007;44:233–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Naqvi H, Jaiswar SP, Hussain SR, Ahmad MK, Mahdi F, Mahdi AA. Genomic analysis of missense and silent mutations in CatSper 2 gene in infertile male cases. Int J Biomed Res. 2016;7:588–93. [Google Scholar]
  • 14. Karger L, Khan WA, Calabio R, Singh R, Xiang B, Babu A, et al. Maternal uniparental disomy of chromosome 15 and concomitant STRC and CATSPER2 deletion‐mediated deafness‐infertility syndrome. Am J Med Genet A. 2017;173:1436–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Luo T, Chen H‐Y, Zou Q‐X, Wang T, Cheng Y‐M, Wang H‐F, et al. A novel copy number variation in CATSPER2 causes idiopathic male infertility with normal semen parameters. Hum Reprod. 2019;34:414–23. [DOI] [PubMed] [Google Scholar]
  • 16. Oviedo N, Ortiz‐Borrayo L, Hernández‐Sánchez J, Jiménez‐Badillo SE, Tesoro‐Cruz E, Moreno‐Navor E, et al. Human CATSPER1 promoter is regulated by CREB1 and CREMτ transcriptional factors In vitro. Arch Med Res. 2018;49:135–46. [DOI] [PubMed] [Google Scholar]
  • 17. Bokar JA, Roesler WJ, Vandenbark GR, Kaetzel DM, Hanson RW, Nilson JH. Characterization of the cAMP responsive elements from the genes for the alpha‐subunit of glycoprotein hormones and phosphoenolpyruvate carboxykinase (GTP). Conserved features of nuclear protein binding between tissues and species. J Biol Chem. 1988;263:19740–7. [PubMed] [Google Scholar]
  • 18. Sassone‐Corsi P. Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol. 1995;11:355–77. [DOI] [PubMed] [Google Scholar]
  • 19. Foulkes NS, Mellström B, Benusiglio E, Sassone‐Corsi P. Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature. 1992;355:80–4. [DOI] [PubMed] [Google Scholar]
  • 20. Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schütz G. Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature. 1996;380:162–5. [DOI] [PubMed] [Google Scholar]
  • 21. Kosir R, Juvan P, Perse M, Budefeld T, Majdic G, Fink M, et al. Novel insights into the downstream pathways and targets controlled by transcription factors CREM in the testis. PLoS ONE. 2012;7:e31798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kim S, Yu N‐K, Kaang B‐K. CTCF as a multifunctional protein in genome regulation and gene expression. Exp Mol Med. 2015;47:e166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Hernández‐Hernández A, Lilienthal I, Fukuda N, Galjart N, Höög C. CTCF contributes in a critical way to spermatogenesis and male fertility. Sci Rep. 2016;6:28355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Kurihara M, Shiraishi A, Satake H, Kimura AP. A conserved noncoding sequence can function as a spermatocyte‐specific enhancer and a bidirectional promoter for a ubiquitously expressed gene and a testis‐specific long noncoding RNA. J Mol Biol. 2014;426:3069–93. [DOI] [PubMed] [Google Scholar]
  • 25. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory‐efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model‐based analysis of ChIP‐seq (MACS). Genome Biol. 2008;9:R137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, et al. deepTools2: a next generation web server for deep‐sequencing data analysis. Nucleic Acids Res. 2016;44:W160–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Lesch BJ, Dokshin GA, Young RA, McCarrey JR, Page DC. A set of genes critical to development is epigenetically poised in mouse germ cells from fetal stages through completion of meiosis. Proc Natl Acad Sci USA. 2013;110:16061–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014;515:355–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Hammoud SS, Low DHP, Yi C, Carrell DT, Guccione E, Cairns BR. Chromatin and transcription transitions of mammalian adult germline stem cells and spermatogenesis. Cell Stem Cell. 2014;15:239–53. [DOI] [PubMed] [Google Scholar]
  • 31. Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang MD, et al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet. 2013;45:1198–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Gardiner‐Garden M, Frommer M. CpG Islands in vertebrate genomes. J Mol Biol. 1987;196:261–82. [DOI] [PubMed] [Google Scholar]
  • 33. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Wang Z, Schones DE, Zhao K. Characterization of human epigenomes. Curr Opin Genet Dev. 2009;19:127–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Nightingale KP, O'Neill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev. 2006;16:125–36. [DOI] [PubMed] [Google Scholar]
  • 37. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol. 2005;6:838–49. [DOI] [PubMed] [Google Scholar]
  • 38. Kanemura S, Matsusaki M, Inaba K, Okumura M. PDI family members as guides for client folding and assembly. Int J Mol Sci. 2020;21:9351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Matsusaki M, Kanemura S, Kinoshita M, Lee Y‐H, Inaba K, Okumura M. The protein disulfide isomerase family: from proteostasis to pathogenesis. Biochim Biophys Acta Gen Subj. 2020;1864:129338. [DOI] [PubMed] [Google Scholar]
  • 40. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet. 2011;12:7–18. [DOI] [PubMed] [Google Scholar]
  • 41. Jangid RK, Kelkar A, Muley VY, Galande S. Bidirectional promoters exhibit characteristic chromatin modification signature associated with transcription elongation in both sense and antisense directions. BMC Genomics. 2018;19:313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Don J, Stelzer G. The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. Mol Cell Endocrinol. 2002;187:115–24. [DOI] [PubMed] [Google Scholar]
  • 43. Martianov I, Choukrallah M‐A, Krebs A, Ye T, Legras S, Rijkers E, et al. Cell‐specific occupancy of an extended repertoire of CREM and CREB binding loci in male germ cells. BMC Genomics. 2010;11:530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Li HG, Ding XF, Liao AH, Kong XB, Xiong CL. Expression of CatSper family transcripts in the mouse testis during post‐natal development and human ejaculated spermatozoa: relationship to sperm motility. Mol Hum Reprod. 2007;13:299–306. [DOI] [PubMed] [Google Scholar]
  • 45. Jiménez‐Badillo SE, Oviedo N, Hernández‐Guzmán C, González‐Mariscal L, Hernández‐Sánchez J. Catsper1 promoter is bidirectional and regulates the expression of a novel lncRNA. Sci Rep. 2017;7:13351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Xia B, Yan Y, Baron M, Wagner F, Barkley D, Chiodin M, et al. Widespread transcriptional scanning in the testis modulates gene evolution rates. Cell. 2020;180:248–62.e21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Mata‐Rocha M, Alvarado‐Cuevas E, Hernández‐Sánchez J, Cerecedo D, Felix R, Hernández‐Reyes A, et al. Molecular cloning and analysis of the catsper1 gene promoter. Mol Hum Reprod. 2013;19:336–47. [DOI] [PubMed] [Google Scholar]
  • 48. Hughes AL, Kelley JR, Klose RJ. Understanding the interplay between CpG Island‐associated gene promoters and H3K4 methylation. Biochim Biophys Acta Gene Regul Mech. 2020;1863:194567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Mitsis T, Efthimiadou A, Bacopoulou F, Vlachakis D, Chrousos PG, Eliopoulos E. Transcription factors and evolution: an integral part of gene expression (review). World Acad Sci J. 2020;2:3–8. [Google Scholar]
  • 50. Novina CD, Roy AL. Core promoters and transcriptional control. Trends Genet. 1996;12:351–5. [PubMed] [Google Scholar]
  • 51. Butler JEF, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev. 2002;16:2583–92. [DOI] [PubMed] [Google Scholar]
  • 52. Moses AM, Chiang DY, Pollard DA, Iyer VN, Eisen MB. MONKEY: identifying conserved transcription‐factor binding sites in multiple alignments using a binding site‐specific evolutionary model. Genome Biol. 2004;5:R98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Steger K, Behr R, Kleiner I, Weinbauer GF, Bergmann M. Expression of activator of CREM in the testis (ACT) during normal and impaired spermatogenesis: correlation with CREM expression. Mol Hum Reprod. 2004;10:129–35. [DOI] [PubMed] [Google Scholar]
  • 54. Delmas V, van der Hoorn F, Mellström B, Jégou B, Sassone‐Corsi P. Induction of CREM activator proteins in spermatids: down‐stream targets and implications for haploid germ cell differentiation. Mol Endocrinol. 1993;7:1502–14. [DOI] [PubMed] [Google Scholar]
  • 55. Kistler MK, Sassone‐Corsi P, Kistler WS. Identification of a functional cyclic adenosine 3′,5′‐monophosphate response element in the 5′‐flanking region of the gene for transition protein 1 (TP1), a basic chromosomal protein of mammalian spermatids. Biol Reprod. 1994;51:1322–9. [DOI] [PubMed] [Google Scholar]
  • 56. Sun Z, Sassone‐Corsi P, Means AR. Calspermin gene transcription is regulated by two cyclic AMP response elements contained in an alternative promoter in the calmodulin kinase IV gene. Mol Cell Biol. 1995;15:561–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Zhou Y, Sun Z, Means AR, Sassone‐Corsi P, Bernstein KE. cAMP‐response element modulator tau is a positive regulator of testis angiotensin converting enzyme transcription. Proc Natl Acad Sci USA. 1996;93:12262–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Ha H, van Wijnen AJ, Hecht NB. Tissue‐specific protein‐DNA interactions of the mouse protamine 2 gene promoter. J Cell Biochem. 1997;64:94–105. [PubMed] [Google Scholar]
  • 59. Rajkovic M, Iwen KAH, Hofmann PJ, Harneit A, Weitzel JM. Functional cooperation between CREM and GCNF directs gene expression in haploid male germ cells. Nucleic Acids Res. 2010;38:2268–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Rhee HS, Pugh BF. Comprehensive genome‐wide protein‐DNA interactions detected at single‐nucleotide resolution. Cell. 2011;147:1408–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Huang X, Gao X, Li W, Jiang S, Li R, Hong H, et al. Stable H3K4me3 is associated with transcription initiation during early embryo development. Bioinformatics. 2019;35:3931–6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data supporting this study's findings are available from the corresponding author (javierh@cinvestav.mx) upon reasonable request.


Articles from FEBS Open Bio are provided here courtesy of Wiley

RESOURCES